BenevolentAI

Uniting AI and science to discover new medicines

BenevolentAI empowers scientists to uncover new insights from data, accelerating innovation and increasing the probability of discovering successful drugs. The company's drug discovery platform leverages multi-modal data foundations, built with expert scientists. BenevolentAI partners with leading pharmaceutical and biotech companies to tackle therapeutic challenges, developing novel treatments for complex multifactorial diseases. By harnessing advanced AI, the company enables biopharmaceutical companies and internal scientists to make higher-confidence decisions and improve research productivity.